Reply to the Letter to the Editor “Is It Time to Abandon Drug-Eluting Stents for Saphenous Venous Graft Percutaneous Coronary Intervention?”

EuroIntervention - France
doi 10.4244/eij-d-18-00666r
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Europa Digital & Publishing

Related search

Is It Time to Abandon Drug-Eluting Stents for Saphenous Venous Graft Percutaneous Coronary Intervention?

EuroIntervention
MedicineCardiovascular MedicineCardiology
2019English

Long-Term Comparison of Everolimus-Eluting Stents With Sirolimus- And Paclitaxel-Eluting Stents for Percutaneous Coronary Intervention of Saphenous Vein Grafts

EuroIntervention
MedicineCardiovascular MedicineCardiology
2014English

Risk of Non-Cardiac Surgery After Percutaneous Coronary Intervention With Drug-Eluting Stents

Scientific Reports
Multidisciplinary
2017English

Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Drug-Eluting Stents

Anesthesiology
AnesthesiologyPain Medicine
2008English

Outcomes With Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Patients With Diabetes Mellitus: Can Newer Generation Drug-Eluting Stents Bridge the Gap?

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2014English

Percutaneous Coronary Intervention in the Drug-Eluting Stent Era

Nihon Shuchu Chiryo Igakukai zasshi
2006English

Reply to Letter to the Editor

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2018English

Reply to “Letter to the Editor”

Oral Oncology
Cancer ResearchOral SurgeryOncology
2010English

Reply to Letter to the Editor

Clinical Orthopaedics and Related Research
MedicineSurgeryOrthopedicsSports MedicineSports Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy